Expression of peptide transporter following intestinal transplantation in the rat

Hideyuki Motohashi, Satohiro Masuda, Toshiya Katsura, Hideyuki Saito, Seisuke Sakamoto, Shinji Uemoto, Koichi Tanaka, Ken Ichi Inui

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background. The absorptive function of the intestinal graft is one of the most important factors for successful intestinal transplantation. To clarify whether the intestinal H+/peptide cotransporter (PEPT1) was expressed in the transplanted intestine, we examined the expression of PEPT1 in an experimental model of rat small intestinal transplantation in comparison with expression of Na+/glucose cotransporter (SGLT1). Materials and methods. Heterotopic intestinal trans-plantation was performed in allogeneic and syngeneic rat strain combinations. An additional group of allogeneic recipients was treated with tacrolimus (1 mg/ kg) prior to transplantation, then daily for 7 days. Intestinal grafts were examined for histopathology and PEPT1 and SGLT1 expression. Results. In the isografts, the levels of messenger RNA (mRNA) encoding both transporters were not changed, while the amount of SGLT1 protein was decreased and that of PEPT1 protein was increased. In the allografts, mRNA level and protein amount of both transporters and the amount of villin protein were decreased, and microscopic examination revealed histopathological features of rejection on day 7. Tacrolimus treatment ameliorated the histopathological features and prevented the decrease in villin protein expression. However, the decreases in PEPT1 and SGLT1 expression (both mRNA and protein) were partially prevented by tacrolimus treatment. Conclusions. This study indicated that the expression of transporters should be determined to evaluate intestinal graft function in addition to histopathological examination of the mucosa and that the levels of mRNA encoding intestinal nutrient transporters in biopsy specimens may be useful for evaluating the intestinal graft function for intestinal transplant patients.

Original languageEnglish
Pages (from-to)294-300
Number of pages7
JournalJournal of Surgical Research
Volume99
Issue number2
DOIs
Publication statusPublished - Jan 1 2001
Externally publishedYes

Fingerprint

Transplantation
Transplants
Tacrolimus
Messenger RNA
Proteins
Sodium-Glucose Transporter 1
Isografts
Intestines
Allografts
Mucous Membrane
Theoretical Models
intestinal peptide-proton cotransporter
Biopsy
Glucose
Food
Peptides
Therapeutics
villin

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Motohashi, H., Masuda, S., Katsura, T., Saito, H., Sakamoto, S., Uemoto, S., ... Inui, K. I. (2001). Expression of peptide transporter following intestinal transplantation in the rat. Journal of Surgical Research, 99(2), 294-300. https://doi.org/10.1006/jsre.2001.6163

Expression of peptide transporter following intestinal transplantation in the rat. / Motohashi, Hideyuki; Masuda, Satohiro; Katsura, Toshiya; Saito, Hideyuki; Sakamoto, Seisuke; Uemoto, Shinji; Tanaka, Koichi; Inui, Ken Ichi.

In: Journal of Surgical Research, Vol. 99, No. 2, 01.01.2001, p. 294-300.

Research output: Contribution to journalArticle

Motohashi, H, Masuda, S, Katsura, T, Saito, H, Sakamoto, S, Uemoto, S, Tanaka, K & Inui, KI 2001, 'Expression of peptide transporter following intestinal transplantation in the rat', Journal of Surgical Research, vol. 99, no. 2, pp. 294-300. https://doi.org/10.1006/jsre.2001.6163
Motohashi, Hideyuki ; Masuda, Satohiro ; Katsura, Toshiya ; Saito, Hideyuki ; Sakamoto, Seisuke ; Uemoto, Shinji ; Tanaka, Koichi ; Inui, Ken Ichi. / Expression of peptide transporter following intestinal transplantation in the rat. In: Journal of Surgical Research. 2001 ; Vol. 99, No. 2. pp. 294-300.
@article{e6934c3e8ed94e12aa70ee87fb017783,
title = "Expression of peptide transporter following intestinal transplantation in the rat",
abstract = "Background. The absorptive function of the intestinal graft is one of the most important factors for successful intestinal transplantation. To clarify whether the intestinal H+/peptide cotransporter (PEPT1) was expressed in the transplanted intestine, we examined the expression of PEPT1 in an experimental model of rat small intestinal transplantation in comparison with expression of Na+/glucose cotransporter (SGLT1). Materials and methods. Heterotopic intestinal trans-plantation was performed in allogeneic and syngeneic rat strain combinations. An additional group of allogeneic recipients was treated with tacrolimus (1 mg/ kg) prior to transplantation, then daily for 7 days. Intestinal grafts were examined for histopathology and PEPT1 and SGLT1 expression. Results. In the isografts, the levels of messenger RNA (mRNA) encoding both transporters were not changed, while the amount of SGLT1 protein was decreased and that of PEPT1 protein was increased. In the allografts, mRNA level and protein amount of both transporters and the amount of villin protein were decreased, and microscopic examination revealed histopathological features of rejection on day 7. Tacrolimus treatment ameliorated the histopathological features and prevented the decrease in villin protein expression. However, the decreases in PEPT1 and SGLT1 expression (both mRNA and protein) were partially prevented by tacrolimus treatment. Conclusions. This study indicated that the expression of transporters should be determined to evaluate intestinal graft function in addition to histopathological examination of the mucosa and that the levels of mRNA encoding intestinal nutrient transporters in biopsy specimens may be useful for evaluating the intestinal graft function for intestinal transplant patients.",
author = "Hideyuki Motohashi and Satohiro Masuda and Toshiya Katsura and Hideyuki Saito and Seisuke Sakamoto and Shinji Uemoto and Koichi Tanaka and Inui, {Ken Ichi}",
year = "2001",
month = "1",
day = "1",
doi = "10.1006/jsre.2001.6163",
language = "English",
volume = "99",
pages = "294--300",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of peptide transporter following intestinal transplantation in the rat

AU - Motohashi, Hideyuki

AU - Masuda, Satohiro

AU - Katsura, Toshiya

AU - Saito, Hideyuki

AU - Sakamoto, Seisuke

AU - Uemoto, Shinji

AU - Tanaka, Koichi

AU - Inui, Ken Ichi

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background. The absorptive function of the intestinal graft is one of the most important factors for successful intestinal transplantation. To clarify whether the intestinal H+/peptide cotransporter (PEPT1) was expressed in the transplanted intestine, we examined the expression of PEPT1 in an experimental model of rat small intestinal transplantation in comparison with expression of Na+/glucose cotransporter (SGLT1). Materials and methods. Heterotopic intestinal trans-plantation was performed in allogeneic and syngeneic rat strain combinations. An additional group of allogeneic recipients was treated with tacrolimus (1 mg/ kg) prior to transplantation, then daily for 7 days. Intestinal grafts were examined for histopathology and PEPT1 and SGLT1 expression. Results. In the isografts, the levels of messenger RNA (mRNA) encoding both transporters were not changed, while the amount of SGLT1 protein was decreased and that of PEPT1 protein was increased. In the allografts, mRNA level and protein amount of both transporters and the amount of villin protein were decreased, and microscopic examination revealed histopathological features of rejection on day 7. Tacrolimus treatment ameliorated the histopathological features and prevented the decrease in villin protein expression. However, the decreases in PEPT1 and SGLT1 expression (both mRNA and protein) were partially prevented by tacrolimus treatment. Conclusions. This study indicated that the expression of transporters should be determined to evaluate intestinal graft function in addition to histopathological examination of the mucosa and that the levels of mRNA encoding intestinal nutrient transporters in biopsy specimens may be useful for evaluating the intestinal graft function for intestinal transplant patients.

AB - Background. The absorptive function of the intestinal graft is one of the most important factors for successful intestinal transplantation. To clarify whether the intestinal H+/peptide cotransporter (PEPT1) was expressed in the transplanted intestine, we examined the expression of PEPT1 in an experimental model of rat small intestinal transplantation in comparison with expression of Na+/glucose cotransporter (SGLT1). Materials and methods. Heterotopic intestinal trans-plantation was performed in allogeneic and syngeneic rat strain combinations. An additional group of allogeneic recipients was treated with tacrolimus (1 mg/ kg) prior to transplantation, then daily for 7 days. Intestinal grafts were examined for histopathology and PEPT1 and SGLT1 expression. Results. In the isografts, the levels of messenger RNA (mRNA) encoding both transporters were not changed, while the amount of SGLT1 protein was decreased and that of PEPT1 protein was increased. In the allografts, mRNA level and protein amount of both transporters and the amount of villin protein were decreased, and microscopic examination revealed histopathological features of rejection on day 7. Tacrolimus treatment ameliorated the histopathological features and prevented the decrease in villin protein expression. However, the decreases in PEPT1 and SGLT1 expression (both mRNA and protein) were partially prevented by tacrolimus treatment. Conclusions. This study indicated that the expression of transporters should be determined to evaluate intestinal graft function in addition to histopathological examination of the mucosa and that the levels of mRNA encoding intestinal nutrient transporters in biopsy specimens may be useful for evaluating the intestinal graft function for intestinal transplant patients.

UR - http://www.scopus.com/inward/record.url?scp=0034895043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034895043&partnerID=8YFLogxK

U2 - 10.1006/jsre.2001.6163

DO - 10.1006/jsre.2001.6163

M3 - Article

VL - 99

SP - 294

EP - 300

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -